Abstract
Bayer CropScience AG owns U.S. Patent No. 6,153,401, which claims a genetically modified plant that incorporates a tfdA gene.1 Because of the product of this gene, the plant can resist a weed herbicide, 2,4-dichlorophenoxyacetic acid (2,4-D).2 The biological action associated with the tfdA gene is degradation of 2,4-D into 2,4-dichlorophenol (2,4-DCP) by an enzyme encoded by the tfdA gene.3 This enzyme was mistakenly known as a “monooxygenase” among the scientific community when Bayer was developing the invention.4
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
